Back

An extensive proteomic analysis of patients with atrial fibrillation reveals relevant clinical pathways

13 May 2024 (08:47 - 08:55)
Organised by: Logo
Congress Presentation Part of: Patient phenotypes and heart failure management Biomarkers HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Ms Maria Papavasileiou

University Medical Centre Groningen, Groningen (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Cytotoxic T-cells drive cardiac inflammation in dilated cardiomyopathy
Mr M. Sikking (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Prognosis of heart failure patients with improved ejection fraction: is there a full recovery?
Doctor I. Gomes Campos (Penafiel, PT)
Abstract Slides Video
Presentation thumbnail
Oral microbiome alterations in heart failure: unveiling potential biomarkers and pathways for diagnosis and severity prediction
Doctor Q. Wu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Heart failure with recovered left ventricle ejection fraction: can we predict it?
Doctor N. Ilchyshyn (Almada, PT)
Abstract Slides Video
Presentation thumbnail
The sex-specific incidence and contribution of modifiable risk factors on new-onset heart failure with reduced and preserved ejection fraction.
Mr B. Van Essen (Groningen, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Patient phenotypes and heart failure management
Video

The Event

Event poster

Heart Failure 2024

13 May 2024 08:47 CET
You may be interested in
thumbnail
Congress Presentation
Proteomic biomarkers and biological mechanisms associated with atrial fibrillation in heart failure patients
thumbnail
Congress Session
Patient phenotypes and heart failure management
thumbnail
Congress Session
The interplay between atrial fibrillation and heart failure: implications for clinicians

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources